Barclays PLC Hutchmed (China) LTD Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Barclays PLC holds 152 shares of HCM stock, worth $2,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152

Previous 152 -0.0%

Holding current value

$2,099

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$16.03 - $20.31 $2,436 - $3,087	152 New	152 $3,000
Q1 2024 May 15, 2024	SELL	$12.08 - $18.56 $184,666 - $283,726	-15,287 Reduced 33.29%	30,631 $515,000
Q1 2023 May 04, 2023	BUY	$13.02 - $19.87 $467,196 - $712,995	35,883 Added 357.58%	45,918 $598,000
Q4 2022 Feb 13, 2023	SELL	$7.65 - $15.51 $460,262 - $933,159	-60,165 Reduced 85.71%	10,035 $148,000
Q3 2022 Nov 03, 2022	BUY	$8.63 - $15.52 $97,519 - $175,376	11,300 Added 19.19%	70,200 $622,000
Q2 2022 Aug 12, 2022	SELL	$8.59 - $20.77 $911,399 - $2.2 Million	-106,100 Reduced 64.3%	58,900 $744,000
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $1.56 Million - $3.58 Million	100,400 Added 155.42%	165,000 $3.12 Million
Q4 2021 Feb 14, 2022	SELL	$28.89 - $35.33 $17,594 - $21,515	-609 Reduced 0.93%	64,600 $2.27 Million
Q3 2021 Nov 09, 2021	SELL	$35.66 - $42.94 $1.68 Million - $2.03 Million	-47,177 Reduced 41.98%	65,209 $2.39 Million
Q2 2021 Aug 13, 2021	BUY	$23.7 - $39.27 $1.56 Million - $2.59 Million	65,892 Added 141.72%	112,386 $4.41 Million
Q1 2021 May 13, 2021	SELL	$27.01 - $36.8 $895,165 - $1.22 Million	-33,142 Reduced 41.62%	46,494 $1.31 Million
Q4 2020 Feb 11, 2021	BUY	$27.51 - $34.36 $1.47 Million - $1.84 Million	53,500 Added 204.7%	79,636 $2.55 Million
Q3 2020 Nov 12, 2020	BUY	$25.8 - $34.61 $291,540 - $391,093	11,300 Added 76.17%	26,136 $844,000
Q2 2020 Aug 12, 2020	BUY	$17.65 - $28.05 $32,405 - $51,499	1,836 Added 14.12%	14,836 $409,000
Q1 2020 May 13, 2020	SELL	$15.19 - $29.51 $319,916 - $621,510	-21,061 Reduced 61.83%	13,000 $232,000
Q4 2019 Feb 10, 2020	BUY	$17.17 - $25.95 $290,464 - $438,996	16,917 Added 98.68%	34,061 $854,000
Q3 2019 Nov 14, 2019	BUY	$17.84 - $22.69 $119,385 - $151,841	6,692 Added 64.03%	17,144 $305,000
Q2 2019 Aug 14, 2019	SELL	$22.0 - $31.78 $120,956 - $174,726	-5,498 Reduced 34.47%	10,452 $230,000
Q1 2019 May 15, 2019	SELL	$21.27 - $30.58 $404,215 - $581,142	-19,004 Reduced 54.37%	15,950 $488,000
Q4 2018 Feb 14, 2019	BUY	$23.09 - $37.69 $807,087 - $1.32 Million	34,954 New	34,954 $807,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.96M

Call Options Held

6.2K

Put Options Held

1.1K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.39B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account